News about Logistics & Distribution

Haffkine Biopharma to produce 22.8 crore Covaxin doses per annum

Haffkine Biopharma to produce 22.8 crore Covaxin doses per annum

Haffkine Biopharma, a Maharashtra state PSU proposed to produce 22.8 crore Covaxin doses per annum under technology transfer arrangement with Bharat Biotech. The production will take place at the Parel complex of the company in Mumbai

Logistics & Distribution | 02/06/2021 | By Darshana |  292

Jenburkt Pharmaceuticals second in India to launch Favipiravir to fight COVID-19

Jenburkt Pharmaceuticals second in India to launch Favipiravir to fight COVID-19

Jenburkt Pharmaceuticals announced the launch of antiviral drug Favipiravir (brand name Favivent) for the treatment of mild to moderate COVID-19 symptoms at a price of Rs. 39/- per tablet

Logistics & Distribution | 24/07/2020 | By Darshana |  521

Roche announces 2-year risdiplam data from SUNFISH and new data from JEWELFISH in infants, children and adults with spinal muscular atrophy (SMA)

Roche announces 2-year risdiplam data from SUNFISH and new data from JEWELFISH in infants, children and adults with spinal muscular atrophy (SMA)

Roche today presented two-year data from Part 1 of its pivotal SUNFISH trial in people aged 2-25 years with Type 2 or 3 spinal muscular atrophy (SMA) at the virtual Cure SMA Annual Conference, 8-12 June, 2020

Logistics & Distribution | 15/06/2020 | By Darshana |  514

Updated data demonstrate Roche's Alecensa increases overall survival rate for people with ALK-positive non-small cell lung cancer

Updated data demonstrate Roche's Alecensa increases overall survival rate for people with ALK-positive non-small cell lung cancer

These data confirm the longer-term efficacy of Alecensa already demonstrated across three phase III clinical trials. Full findings were presented at the ASCO20 Virtual Scientific Programme, on 29 May 2020

Logistics & Distribution | 01/06/2020 | By Darshana |  464

GSK Pharma to discontinue manufacture & supply of Zinetac tablets in India

GSK Pharma to discontinue manufacture & supply of Zinetac tablets in India

GlaxoSmithKline Pharmaceuticals announced that the company has decided to discontinue the manufacture and supply of Zinetac tablets, used to treat and prevent heartburn

Logistics & Distribution | 22/05/2020 | By Darshana |  757

Cipla files ANDA for generic version of GSK's Advair Diskus to US FDA

Cipla files ANDA for generic version of GSK's Advair Diskus to US FDA

Cipla Limited announced its submission of an Abbreviated New Drug Application (ANDA) for fluticasone propionate and salmeterol inhalation powder (100/50 mcg, 250/50 mcg and 500/50 mcg) to the United States Food and Drug Administration (FDA)

Logistics & Distribution | 20/05/2020 | By Darshana |  516

FDA Authorizes First Diagnostic Test Using At-Home Collection of Saliva Specimens

FDA Authorizes First Diagnostic Test Using At-Home Collection of Saliva Specimens

Today, the U.S. Food and Drug Administration authorized the first diagnostic test with the option of using home-collected saliva samples for COVID-19 testing

Logistics & Distribution | 10/05/2020 | By Darshana |  344

Pune based companies develop ImmunoQuick Rapid COVID-19 TEST kit

Pune based companies develop ImmunoQuick Rapid COVID-19 TEST kit

Unlike ordinary antibody tests, ImmunoQuick Covid-19 test separates the two forms of antibodies IgM and IgG into separate bands. This has enormous advantages because clinicians can now separate patients into early infections, active patients and resolved/cured patients

Logistics & Distribution | 21/04/2020 | By Darshana |  1176

Roche develops new serology test to detect COVID-19 antibodies

Roche develops new serology test to detect COVID-19 antibodies

Roche announced the development and upcoming launch of its Elecsys Anti-SARS-CoV-2 serology test to detect antibodies in people who have been exposed to the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) that causes the COVID-19 disease

Logistics & Distribution | 19/04/2020 | By Darshana |  332

Sanofi to donate 100 million doses of hydroxychloroquine across 50 countries

Sanofi to donate 100 million doses of hydroxychloroquine across 50 countries

Sanofi has committed to donating 100 million doses of hydroxychloroquine to 50 countries around the world, and has begun to progressively deliver the medicine to authorities that have requested it

Logistics & Distribution | 13/04/2020 | By Darshana |  348

 
 

 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members